Purpose: We investigated the intraocular pressure (IOP) variations after switching from 0.005% latanoprost to 0.01% bimatoprost in open-angle glaucoma patients who experienced IOP elevation during ...

Similarly, the Apteryx study assessed the additive IOP-lowering efficacy, as well as the safety and tolerability of the therapy when dosed alongside latanoprost versus latanoprost alone.